Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
…, S Oshima, T Aoki, N Higaki, K Sugimoto… - Clinical cancer research …, 1998 - AACR
We investigated the presence of K-ras gene mutation in plasma DNA and assessed its
clinical value in patients with pancreatic adenocarcinoma. Mutations in codon 12 of the K-ras …
clinical value in patients with pancreatic adenocarcinoma. Mutations in codon 12 of the K-ras …
[HTML][HTML] Molecular Cloning and Characterization of a Newly Identified Member of the Cadherin Family, PB-cadherin (∗)
K Sugimoto, S Honda, T Yamamoto, T Ueki… - Journal of Biological …, 1996 - ASBMB
We have isolated cDNA clones encoding novel proteins belonging to the cadherin family.
These novel proteins are encoded by two distinct mRNA species generated by alternative …
These novel proteins are encoded by two distinct mRNA species generated by alternative …
Pretreatment with S-1, an oral derivative of 5-fluorouracil, enhances gemcitabine effects in pancreatic cancer xenografts
…, S Nakamori, M Tsujie, S Takeda, K Sugimoto… - Anticancer …, 2008 - ar.iiarjournals.org
Background: The systemic administration of gemcitabine (GEM) has been accepted as a
standard treatment for patients with advanced pancreatic cancer. The major mediator of cellular …
standard treatment for patients with advanced pancreatic cancer. The major mediator of cellular …
Optimal timing of laparoscopic cholecystectomy after gallbladder drainage for acute cholecystitis: a multi‐institutional retrospective study
…, H Hatano, J Shimizu, K Sugimoto… - Journal of Hepato …, 2020 - Wiley Online Library
Background There is no consensus on the optimal timing of laparoscopic cholecystectomy (LC)
after gallbladder drainage for acute cholecystitis (AC). To obtain evidence for a …
after gallbladder drainage for acute cholecystitis (AC). To obtain evidence for a …
Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi‐institutional …
…, T Kishimoto, K Danno, K Sugimoto… - Annals of …, 2023 - Wiley Online Library
Aims Risk‐scoring systems for colorectal liver metastasis (CRLM) after hepatectomy allow
prognoses to be predicted preoperatively. We investigated the clinical outcomes of …
prognoses to be predicted preoperatively. We investigated the clinical outcomes of …
[HTML][HTML] Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy …
…, M Murakami, Y Kim, S Nakahira, N Hama, K Sugimoto… - Trials, 2021 - Springer
Background Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease, and multimodal
strategies, such as surgery plus neoadjuvant chemotherapy (NAC)/adjuvant chemotherapy, …
strategies, such as surgery plus neoadjuvant chemotherapy (NAC)/adjuvant chemotherapy, …
Pilot study of a combination of S-1 and paclitaxel for patients with peritoneal metastasis from gastric cancer
…, C Egawa, K Nakata, S Okamura, K Sugimoto… - Gastric Cancer, 2010 - Springer
Background This pilot study was carried out to evaluate the efficacy of chemotherapy for
patients with peritoneal dissemination from gastric cancer or positive lavage cytology diagnosed …
patients with peritoneal dissemination from gastric cancer or positive lavage cytology diagnosed …
Influence of Percutaneous Transhepatic Gallbladder Aspiration and Drainage for Severe Acute Cholecystitis on the Surgical Outcomes of Subsequent Laparoscopic …
…, H Hatano, J Shimizu, K Sugimoto… - Surgical Laparoscopy …, 2024 - journals.lww.com
Objective: Percutaneous transhepatic gallbladder aspiration (PTGBA) and/or drainage (PTGBD)
are useful approaches in the management of acute cholecystitis in patients who cannot …
are useful approaches in the management of acute cholecystitis in patients who cannot …
Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer
…, K Okada, S Nakahira, S Okamura, K Sugimoto… - Gastric Cancer, 2007 - Springer
We report a patient with type 3 gastric cancer with peritoneal dissemination and
hydronephrosis who was successfully treated with intraperitoneal infusion of paclitaxel and oral …
hydronephrosis who was successfully treated with intraperitoneal infusion of paclitaxel and oral …
Pilot study of intraperitoneal administration of paclitaxel and oral S-1 for patients with peritoneal metastasis due to advanced gastric cancer
…, S Nakahira, K Nakata, S Okamura, K Sugimoto… - International journal of …, 2008 - Springer
Background There is no standard treatment for peritoneal dissemination from gastric cancer.
A novel combination chemotherapy has been introduced for patients with advanced gastric …
A novel combination chemotherapy has been introduced for patients with advanced gastric …